| pubmed-article:15752684 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15752684 | lifeskim:mentions | umls-concept:C0010674 | lld:lifeskim |
| pubmed-article:15752684 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:15752684 | lifeskim:mentions | umls-concept:C0003765 | lld:lifeskim |
| pubmed-article:15752684 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:15752684 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15752684 | pubmed:dateCreated | 2005-3-8 | lld:pubmed |
| pubmed-article:15752684 | pubmed:abstractText | Exhaled nitric oxide has previously been found to be low in cystic fibrosis. The aim of this study was to determine whether exhaled nitric oxide levels would increase in response to oral L-arginine supplementation administered daily for 4 weeks. Exhaled and nasal nitric oxide was measured weekly. Plasma L-arginine levels increased in response to supplementation but this was not reflected in an increase in eNO levels. | lld:pubmed |
| pubmed-article:15752684 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15752684 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15752684 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15752684 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15752684 | pubmed:issn | 1569-1993 | lld:pubmed |
| pubmed-article:15752684 | pubmed:author | pubmed-author:DonnellyDD | lld:pubmed |
| pubmed-article:15752684 | pubmed:author | pubmed-author:EverardM LML | lld:pubmed |
| pubmed-article:15752684 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15752684 | pubmed:volume | 4 | lld:pubmed |
| pubmed-article:15752684 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15752684 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15752684 | pubmed:pagination | 67-9 | lld:pubmed |
| pubmed-article:15752684 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:meshHeading | pubmed-meshheading:15752684... | lld:pubmed |
| pubmed-article:15752684 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15752684 | pubmed:articleTitle | A pilot study of oral L-arginine in cystic fibrosis. | lld:pubmed |
| pubmed-article:15752684 | pubmed:affiliation | m.l.everard@sheffield.ac.uk | lld:pubmed |
| pubmed-article:15752684 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15752684 | pubmed:publicationType | Comparative Study | lld:pubmed |
